ロード中...
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
The demonstration that dopamine loss is the key pathological feature of Parkinson's disease (PD), and the subsequent introduction of levodopa have revolutionalized the field of PD therapeutics. This review will discuss the significant progress that has been made in the development of new pharma...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3238085/ https://ncbi.nlm.nih.gov/pubmed/21956442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2011.212 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|